data13F

GENB – Generate Biomedicines Inc

Held by 2 of 60 tracked investors in their latest 13F filing · 1 counted on Most owned (narrow-view filings excluded)

Investors holding2
Combined shares1,994,264
Combined reported value$30.0M

GENB chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Cathie Wood 0.17 Added 52.9%1,964,661$29.5MQ3 2026
Paul Tudor Jones narrow view 0.00 New29,603$445KQ3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Cathie Wood Added 52.9%1,964,6610.06
Q3 2026Paul Tudor Jones narrow view New29,6030.00
Q2 2026Cathie Wood Added 157.7%1,284,6170.09
Q2 2026Paul Tudor Jones narrow view Closed00.00
Q1 2026Cathie Wood New498,4080.05
Q1 2026Paul Tudor Jones narrow view New23,8330.00

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Cathie Wood Added 52.9%1,964,6610.06
Q3 2026Paul Tudor Jones narrow view New29,6030.00
Q2 2026Cathie Wood Added 157.7%1,284,6170.09
Q1 2026Cathie Wood New498,4080.05
Q1 2026Paul Tudor Jones narrow view New23,8330.00

Reduced: reduced or closed

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q2 2026Paul Tudor Jones narrow view Closed00.00

History

2 peakQ3 2026: 2 tracked investors
Q1 2026: 2 tracked investorsQ2 2026: 1 tracked investorsQ3 2026: 2 tracked investors
20262026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Cathie Wood1.96M1.28M498.4K–––––
Paul Tudor Jones29.6K–23.8K–––––

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).